Patrick J. Heron, Director at Mirum Pharmaceuticals, Inc. (MIRM), bought 3,250 shares at $43.89 ($142K) on 2025-03-06, disclosed to the SEC on 2025-03-10.
Open-market purchase of $142k MIRM by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $43.89 | 1,335 | $59K | 41.2% |
| 2 | $43.89 | 1,335 | $59K | 41.2% |
| 3 | $43.21 | 580 | $25K | 17.6% |
| Total | $43.77 avg | 3,250 | $142K | 100% |
| Filing → |
| ARQT | BUY | 2025-06-06 | $30K | — | Filing → |
| ARQT | BUY | 2025-05-23 | $69K | — | Filing → |
| ARQT | BUY | 2025-05-19 | $34K | — | Filing → |